Else Marie Agger

9.1k citations
101 papers · 7.4k · 1 hit paper · h-index 48

Impact in

  • Immunology top 0.2%
    • Immunotherapy and Immune Responses
    • Immune Response and Inflammation
    • Immune Cell Function and Interaction
    • Immunodeficiency and Autoimmune Disorders
  • Infectious Diseases top 0.2%
    • Tuberculosis Research and Epidemiology

Papers in

  • Immunology 74
    • Immunotherapy and Immune Responses 47
    • Immune Response and Inflammation 23
    • Immune Cell Function and Interaction 17
    • Immunodeficiency and Autoimmune Disorders 14
    • T-cell and B-cell Immunology 12
  • Infectious Diseases 47
    • Tuberculosis Research and Epidemiology 41
Co-authors
Peter Andersen (87 shared papers)Dennis Christensen (27 shared papers)Ida Rosenkrands (22 shared papers)Karen Smith Korsholm (12 shared papers)Thomas Lindenstrøm (16 shared papers)Claus Aagaard (12 shared papers)Yvonne Perrie (13 shared papers)Laurens A.H. van Pinxteren (4 shared papers)
Journals
The Journal of Immunology (13 papers)PLoS ONE (13 papers)Vaccine (9 papers)Infection and Immunity (5 papers)Scientific Reports (4 papers)
Partner nations
DenmarkUnited KingdomUnited States

In The Last Decade

Else Marie Agger

101 papers receiving 7.3k citations

Else Marie Agger's Hit Papers

The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons 2016 · 491 citations
4910+3+6Years since publication100200300400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2016 Immunity

Peers

Else Marie Agger
Comparison fields: 5 of 122
  • Immunology 4.8k
  • Infectious Diseases 3.1k
  • Microbiology 562
  • Pharmaceutical Science 417
  • Epidemiology 2.2k
Replace Ennio De Gregorio with:
Ennio De Gregorio Italy
Rhea N. Coler United States
Michael F. Good Australia
Christopher B. Fox United States
Ida Rosenkrands Denmark
John H. Eldridge United States
Steven G. Reed United States
Jeffrey B. Ulmer United States
Kees L. M. C. Franken Netherlands
Margaret A. Liu United States
Else Marie Agger relative to Ennio De Gregorio Italy Ennio De Gregorio's profile →
Citations per field
00.5×1.5×2×2.5×
Ennio De Gregorio · 1×
Citations per year

Countries citing papers authored by Else Marie Agger

Since Specialization
Citations

This map shows the geographic impact of Else Marie Agger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Else Marie Agger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Else Marie Agger more than expected).

Fields of papers citing papers by Else Marie Agger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Else Marie Agger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Else Marie Agger. The network helps show where Else Marie Agger may publish in the future.

Co-authors

The 25 scholars most cited alongside Else Marie Agger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Else Marie Agger Line = papers co-authored together Else Marie Agger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons
Immunity ·Elizabeth C. Carroll, Lei Jin, Andrés Mori, Natalia Muñoz‐Wolf, Ewa Oleszycka, Hannah B.T. Moran, Samira Mansouri, Craig P. McEntee, Eimear M. Lambe, Else Marie Agger, Peter Andersen, Colm Cunningham, Paul J. Hertzog, Katherine A. Fitzgerald, Andrew Bowie, Ed C. Lavelle
Hit paper breakdown →		2016491
2
Cutting Edge: Mincle Is Essential for Recognition and Adjuvanticity of the Mycobacterial Cord Factor and its Synthetic Analog Trehalose-Dibehenate
The Journal of Immunology ·Hanne Schoenen, Barbara Bodendorfer, Kelly Hitchens, Silvia Manzanero, Kerstin Werninghaus, Falk Nimmerjahn, Else Marie Agger, Steffen Stenger, Peter Andersen, Jürgen Ruland, Gordon D. Brown, Christine A. Wells, Roland Lang
2010381
3
Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells
The Journal of Immunology ·Thomas Lindenstrøm, Else Marie Agger, Karen Smith Korsholm, Patricia A. Darrah, Claus Aagaard, Robert A. Seder, Ida Rosenkrands, Peter Andersen
2009351
4
Control of latentMycobacterium tuberculosis infection is dependent on CD8 T cells
European Journal of Immunology ·Laurens A.H. van Pinxteren, Joseph P. Cassidy, Birgitte H. C. Smedegaard, Else Marie Agger, Peter Andersen
2000297
5
Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate)—A novel adjuvant inducing both strong CMI and antibody responses
Biochimica et Biophysica Acta (BBA) - Biomembranes ·Jesper Rømhild Davidsen, Ida Rosenkrands, Dennis Christensen, A. Vangala, Daniel Kirby, Yvonne Perrie, Else Marie Agger, Peter Andersen
2005285
6
Diagnosis of Tuberculosis Based on the Two Specific Antigens ESAT-6 and CFP10
Clinical and Diagnostic Laboratory Immunology ·Laurens A.H. van Pinxteren, Pernille Ravn, Else Marie Agger, J.M. Pollock, Peter Andersen
2000279
7
Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ–Syk–Card9–dependent innate immune activation
The Journal of Experimental Medicine ·Kerstin Werninghaus, Anna Babiak, Olaf Groß, Christoph Hölscher, Harald Dietrich, Else Marie Agger, Jörg Mages, Attila Mócsai, Hanne Schoenen, Katrin Finger, Falk Nimmerjahn, Gordon D. Brown, Carsten J. Kirschning, Antje Heit, Peter Andersen, Hermann Wagner, Jürgen Ruland, Roland Lang
2009258
8
Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements
PLoS ONE ·Else Marie Agger, Ida Rosenkrands, Jon Hansen, Karima Brahimi, Brian Vandahl, Claus Aagaard, Kerstin Werninghaus, Carsten J. Kirschning, Roland Lang, Dennis Christensen, Michael Theisen, Frank Follmann, Peter Andersen
2008233
9
Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6
Vaccine ·Jan A. M. Langermans, T. Mark Doherty, Richard A. W. Vervenne, Tridia van der Laan, Konstantin P. Lyashchenko, Rena Greenwald, Else Marie Agger, Claus Aagaard, H. Weiler, Dick van Soolingen, Wilfried Dalemans, Alan W. Thomas, Peter Andersen
2004207
10
A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human
Vaccine ·Jaap T. van Dissel, Simone A. Joosten, Søren T. Hoff, Darius Soonawala, Corine Prins, David A. Hokey, Dawn M. O’Dee, Andrew J. Graves, Birgit Thierry-Carstensen, Lars Vibe Andreasen, Morten Rühwald, Adriëtte W. de Visser, Else Marie Agger, Tom H. M. Ottenhoff, Ingrid Kromann, Peter Andersen
2014190
11
Cationic liposomes as vaccine adjuvants
Expert Review of Vaccines ·Dennis Christensen, Karen Smith Korsholm, Peter Andersen, Else Marie Agger
2011190
12
Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens
Scientific Reports ·Niels Peter Hell Knudsen, Anja Weinreich Olsen, Cecilia Buonsanti, Frank Follmann, Yuan Zhang, Rhea N. Coler, Christopher B. Fox, Andreas Meinke, Ugo D ́Oro, Daniele Casini, Alessandra Bonci, Rolf Billeskov, Ennio De Gregorio, Rino Rappuoli, Ali M. Harandi, Peter Andersen, Else Marie Agger
2016183
13
The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes
Immunology ·Karen Smith Korsholm, Else Marie Agger, Camilla Foged, Dennis Christensen, Jes Dietrich, Claire Swetman Andersen, Carsten Geisler, Peter Andersen
2007154
14
Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response
Journal of Controlled Release ·Malou Henriksen‐Lacey, Dennis Christensen, Vincent W. Bramwell, Thomas Lindenstrøm, Else Marie Agger, Peter Andersen, Yvonne Perrie
2010137
15
Control of Chronic Mycobacterium tuberculosis Infection by CD4 KLRG1− IL-2–Secreting Central Memory Cells
The Journal of Immunology ·Thomas Lindenstrøm, Niels Peter Hell Knudsen, Else Marie Agger, Peter Andersen
2013136
16
The Mincle-Activating Adjuvant TDB Induces MyD88-Dependent Th1 and Th17 Responses through IL-1R Signaling
PLoS ONE ·Christiane Desel, Kerstin Werninghaus, Manuel Ritter, Katrin Jozefowski, Jens Wenzel, Norman F. Russkamp, Ulrike Schleicher, Dennis Christensen, Stefan Wirtz, Carsten J. Kirschning, Else Marie Agger, Clarissa Prazeres da Costa, Roland Lang
2013123
17
Vaccine-Induced Th17 Cells Are Maintained Long-Term Postvaccination as a Distinct and Phenotypically Stable Memory Subset
Infection and Immunity ·Thomas Lindenstrøm, Joshua S. Woodworth, Jes Dietrich, Claus Aagaard, Peter Andersen, Else Marie Agger
2012111
18
Cationic liposomes as vaccine adjuvants
Expert Review of Vaccines ·Dennis Christensen, Karen Smith Korsholm, Ida Rosenkrands, Thomas Lindenstrøm, Peter Andersen, Else Marie Agger
2007109
19
Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31
Vaccine ·Else Marie Agger, Ida Rosenkrands, Anja Weinreich Olsen, Graham Hatch, Ann Williams, Constantia E. Kritsch, Karen Lingnau, Alexander von Gabain, Claire Swetman Andersen, Karen Smith Korsholm, Peter Andersen
2006100
20
PPE Protein (Rv3873) from DNA Segment RD1 ofMycobacterium tuberculosis: Strong Recognition of Both Specific T-Cell Epitopes and Epitopes Conserved within the PPE Family
Infection and Immunity ·Limei Meng Okkels, Inger Brock, Frank Follmann, Else Marie Agger, Sandra M. Arend, Tom H. M. Ottenhoff, Fredrik Oftung, Ida Rosenkrands, Peter Andersen
200398

About Else Marie Agger

Else Marie Agger is a scholar working on Immunology, Infectious Diseases, Epidemiology, Molecular Biology and Surgery, having authored 101 papers that have together received 7.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (47 papers), Tuberculosis Research and Epidemiology (41 papers), Immune Response and Inflammation (23 papers), Mycobacterium research and diagnosis (23 papers), Immune Cell Function and Interaction (17 papers), RNA Interference and Gene Delivery (15 papers), Immunodeficiency and Autoimmune Disorders (14 papers) and T-cell and B-cell Immunology (12 papers). The work is most often cited by research in Immunology (4.8k citations), Infectious Diseases (3.1k citations), Microbiology (562 citations), Pharmaceutical Science (417 citations) and Epidemiology (2.2k citations). Else Marie Agger has collaborated with scholars based in Denmark, United Kingdom and United States. Frequent co-authors include Peter Andersen, Dennis Christensen, Ida Rosenkrands, Karen Smith Korsholm, Thomas Lindenstrøm, Claus Aagaard, Yvonne Perrie, Laurens A.H. van Pinxteren, Camilla Foged and Joseph P. Cassidy. Their work appears in journals such as The Journal of Immunology, PLoS ONE, Vaccine, Infection and Immunity and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ennio De GregorioBreakdown of academic impact, for papers by Rhea N. ColerBreakdown of academic impact, for papers by Michael F. GoodBreakdown of academic impact, for papers by Christopher B. FoxBreakdown of academic impact, for papers by Ida RosenkrandsBreakdown of academic impact, for papers by John H. EldridgeBreakdown of academic impact, for papers by Steven G. ReedBreakdown of academic impact, for papers by Jeffrey B. UlmerBreakdown of academic impact, for papers by Kees L. M. C. FrankenBreakdown of academic impact, for papers by Margaret A. Liu